Drug intelligence / Profile preview

myrrh

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral, Topical, Inhalation
01

Overview

Myrrh is a natural yellowish resin obtained from the bark of trees in the genus Commiphora, especially Commiphora myrrha. It has been used for centuries in traditional medicine systems worldwide and is also employed as a fragrance and flavoring agent in foods and cosmetics. Myrrh contains various bioactive compounds including sesquiterpenes (such as furanodiene), terpenoids, phenolic acids, volatile oils (myrrhol), and resins (myrrhin). Its pharmacological activities include anti-inflammatory, analgesic (pain-relieving), antioxidant, antimicrobial, cytoprotective, cytotoxic (anti-cancer), hypoglycemic, lipid-lowering effects[1][2][3][5][6]. The mechanism of action involves inhibition of inflammatory pathways such as Nuclear factor kappaB pathway signaling by inducing haem oxygenase activity; suppression of Mitogen activated protein kinase pathway components like p38 and c-jun N-terminal kinase subunit; inhibition of 5-lipoxygenase to reduce leukotriene production; reduction in oxidative stress via increased antioxidant enzyme activity; antibacterial effects attributed to its ether extract fraction[3][5][6]. Myrrh has been studied for use in mild inflammation of oral/pharyngeal mucosa (e.g., gingivitis), wound healing, pain relief for headaches/joint pain/menstrual cramps/back pain[2][3], ulcerative colitis attenuation[5], reproductive health support[6], hepatoprotection[6], and potential anti-cancer properties against prostate cancer cells[5]. However, robust clinical evidence supporting these uses is limited.

Brand names
Mirazid
Other names
Commiphora myrrhagum myrrholeo-gum-resin of CommiphoraAbyssinian myrrh
02

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)JNK (Mitogen-activated protein kinase kinase kinase family)RK (Ribokinase)MAPK14 (p38 mitogen-activated protein kinase alpha)

Beyond the preview

Go deeper on myrrh.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on myrrh.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call